Return to content in this issue


Protocol for Desensitization to Trastuzumab in a Patient With Anaphylaxis and Stage IV Breast Cancer: A Case Report

de Lira-Quezada CE, Villarreal-González RV, González-Díaz SN, Acuña-Ortega N

Regional Center of Allergy and Clinical Immunology, University Hospital “Dr. José Eleuterio González”, Faculty of Medicine, Autonomous University of Nuevo León, Monterrey, Mexico

J Investig Allergol Clin Immunol 2020; Vol 30(5) : 376-377
doi: 10.18176/jiaci.0558

Key words: Trastuzumab, Desensitization, Anaphylaxis, Biologic therapy